ARTiST: Aromasin® Randomised TrIal +/- Sutent® as neoadjuvant Therapy for post-menopausal women with breast cancer
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Exemestane; Sunitinib
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms ARTiST
- 13 Oct 2017 Status changed from completed to discontinued.
- 10 Jun 2017 Biomarkers information updated
- 04 Mar 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.